Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Outputs & Impact
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Daan De Maeseneer
Profile
Projects
Publications & Research Data
Activities
Awards & Distinctions
Patents
40
Results
2026
Does it make sense to perform prostate magnetic resonance imaging in men with normal PSA (<4 ng/mL)?
Pieter De Visschere
Camille Berquin
Pieter De Backer
Joris Vangeneugden
Eva Donck
Thomas Tailly
Valerie Fonteyne
Sofie Verbeke
Sifrid Hendrickx
Nicolaas Lumen
et al.
A1
Journal Article
in
CANCERS
2026
2025
Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints
Flor Verghote
Elke Rammant
Piet Dirix
Charles Van Praet
Charlien Berghen
Sara Junius
Nick Liefhooghe
Leen Noé
Piet Ost
Karel Decaestecker
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2025
Prognostic value of the circulating tumor DNA fraction in metastatic castration-resistant prostate cancer : results from the ProBio platform trial
Alessio Crippa
Bram De Laere
Andrea Discacciati
Berit Larsson
Maria Persson
Susanne Johansson
Sanne D'hondt
Marie Hjälm-Eriksson
Linn Pettersson
Gunilla Enblad
et al.
A1
Journal Article
in
EUROPEAN UROLOGY ONCOLOGY
2025
2024
Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer?
Valerie Fonteyne
Flor Verghote
Camille Berquin
Daan De Maeseneer
Geert Villeirs
Kathia De Man
A2
Journal Article
in
AME CLINICAL TRIALS REVIEW
2024
Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review
Antonio Franco
Thomas Tailly
Camille Berquin
Daan De Maeseneer
Alexander Decruyenaere
Sofie Verbeke
Pieter De Visschere
Kathia De Man
Laurens Hermie
Ben Vanneste
et al.
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2024
Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer
Daan De Maeseneer
Pieter De Visschere
Mats Van den broecke
Felix Delbare
Geert Villeirs
Sofie Verbeke
Valerie Fonteyne
Charles Van Praet
Karel Decaestecker
Alexander Decruyenaere
et al.
A1
Journal Article
in
BMC MEDICAL IMAGING
2024
2023
Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial
Mathieu Spaas
Nora Sundahl
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Fréderic Duprez
Yolande Lievens
Veerle Surmont
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
JAMA ONCOLOGY
2023
Indicaties voor radiotherapie bij blaaskanker met spierinvasie
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
A4
Journal Article
in
ONCO (NEDERLANDSE ED.)
2023
Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
A1
Journal Article
in
CANCER MANAGEMENT AND RESEARCH
2023
Role of radiotherapy as primary treatment for muscle-invasive bladder cancer : review of the guidelines and single-centre pattern of care analysis
Flor Verghote
Charles Van Praet
Daan De Maeseneer
Camille Berquin
Ben Vanneste
Pieter De Visschere
Sofie Verbeke
Valerie Fonteyne
C3
Conference
2023
Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up
Laura Schelfaut
Bart De troyer
Sifrid Hendrickx
Charles Van Praet
Friedl Vanhaverbeke
Sofie Verbeke
Geert Villeirs
Hendrik Wynant
Pieter De Visschere
Nicolaas Lumen
et al.
C3
Conference
2023
The changing landscape of systemic therapy in the treatment of synchronous metastatic hormone-sensitive prostate cancer
Edward Lambert
Nicolaas Lumen
Valerie Fonteyne
Daan De Maeseneer
Sofie Verbeke
Geert Villeirs
Kathia De Man
Charles Van Praet
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2023
2022
Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial
Valerie Fonteyne
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
L. Noé
G. De Meerleer
Piet Ost
et al.
A1
Journal Article
in
EUROPEAN UROLOGY FOCUS
2022
Highlights in genitourinary cancer
Tijl Vermassen
Alexander Decruyenaere
Sylvie Rottey
Daan De Maeseneer
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2022
Highlights in genitourinary cancers
Alexander Decruyenaere
Sylvie Rottey
Daan De Maeseneer
Tijl Vermassen
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2022
Practical guidance for molecular testing in metastatic prostate cancer : a Belgian perspective
Sofie Verbeke
S Verschuere
M-D Martin-Martinez
Bart Lelie
Louis Libbrecht
M Baldewijns
S Rorive
G Beniuga
J Eben
M-A Van Caillie
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2022
The changing landscape of systemic therapy in the treatment of newly-diagnosed metastatic prostate cancer
Nicolaas Lumen
Edward Lambert
Valerie Fonteyne
Daan De Maeseneer
Charles Van Praet
C3
Conference
2022
2021
Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial
Flor Verghote
P. Dirix
Charles Van Praet
C. Berghen
M. Albersen
S. Junius
N. Liefhooghe
M. Brosens
G. De Meerleer
Piet Ost
et al.
C3
Conference
2021
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial
Mathieu Spaas
Nora Sundahl
Eva Hulstaert
Vibeke Kruse
Sylvie Rottey
Daan De Maeseneer
Veerle Surmont
Annabel Meireson
Lieve Brochez
Dries Reynders
et al.
A1
Journal Article
in
BMC CANCER
2021
Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial
Flor Verghote
Lindsay Poppe
Sofie Verbeke
Piet Dirix
Maarten Albersen
Gert De Meerleer
Charlien Berghen
Piet Ost
Geert Villeirs
Pieter De Visschere
et al.
A1
Journal Article
in
BMC CANCER
2021
Highlights in genitourinary cancers
Tijl Vermassen
Sylvie Rottey
Daan De Maeseneer
Other
2021
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
Mathieu Spaas
Nora Sundahl
Sylvie Rottey
VIBEKE KRUSE
Daan De Maeseneer
Fréderic Duprez
Piet Dirix
Veerle Surmont
Yolande Lievens
Robin Van den Begin
et al.
C3
Conference
2021
Retrospective analysis of mpMRI to predict complete pathologic response after neo-adjuvant chemotherapy for muscle invasive bladder cancer
Daan De Maeseneer
Pieter De Visschere
Mats Van den broecke
Geert Villeirs
Karel Decaestecker
Sylvie Rottey
C3
Conference
2021
2020
Targeting FGFR in bladder cancer : ready for clinical practice?
Stijn De Keukeleire
Daan De Maeseneer
Celine Jacobs
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2020
2019
Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?
Tijl Vermassen
Thierry Roumeguere
Yannick Neybuch
Lucien Hoekx
Irena Fele
Brieuc Sautois
Wouter Everaerts
Daan De Maeseneer
Frederic Lecouvet
Nicolaas Lumen
et al.
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2019
Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results
Piet Ost
Nora Sundahl
G Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
et al.
C3
Conference
2019
Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma
Nora Sundahl
Gillian Vandekerkhove
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
A1
Journal Article
in
EUROPEAN UROLOGY
2019
Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results
Gillian Vandekerkhove
Nora Sundahl
Karel Decaestecker
Annabel Meireson
Pieter De Visschere
Valerie Fonteyne
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Jo Van Dorpe
et al.
C3
Conference
2019
2018
Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium
Valerie Fonteyne
Elke Rammant
Piet Ost
Yolande Lievens
Bart De Troyer
Sylvie Rottey
Gert De Meerleer
Daan De Maeseneer
Dirk De Ridder
Karel Decaestecker
A1
Journal Article
in
CLINICAL GENITOURINARY CANCER
2018
Pembrolizumab for the treatment of bladder cancer
Nora Sundahl
Sylvie Rottey
Daan De Maeseneer
Piet Ost
A1
Journal Article
in
EXPERT REVIEW OF ANTICANCER THERAPY
2018
2017
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response
Nora Sundahl
Katrien De Wolf
Sylvie Rottey
Karel Decaestecker
Daan De Maeseneer
Annabel Meireson
Els Goetghebeur
Valerie Fonteyne
Sofie Verbeke
Pieter De Visschere
et al.
A1
Journal Article
in
JOURNAL OF TRANSLATIONAL MEDICINE
2017
Checkpoint inhibition : new treatment options in urologic cancer
Daan De Maeseneer
Brant Delafontaine
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2017
Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial
Katrien De Wolf
Sylvie Rottey
Karim Vermaelen
Karel Decaestecker
Nora Sundahl
Lizzy De Lobel
Els Goetghebeur
Gert De Meerleer
Nicolaas Lumen
Valerie Fonteyne
et al.
A1
Journal Article
in
RADIATION ONCOLOGY
2017
Parathyroid adenoma mimicking a malignant lymph node on F-18-choline PET-CT
Bliede Van den Broeck
Daan De Maeseneer
Ruth De Gersem
Kathia De Man
Editorial material
2017
Prostaatkanker en de rol van de huisarts
Marco Blanker
Kristel van Asselt
Sylvie Rottey
Daan De Maeseneer
Filip Poelaert
Bookchapter
in
Oncologie
2017
2013
Attacking the androgen receptor pathway in prostate cancer
Charles Van Praet
Daan De Maeseneer
Nicolaas Lumen
Sylvie Rottey
A2
Journal Article
in
BELGIAN JOURNAL OF MEDICAL ONCOLOGY
2013
Multicenter cross-sectional study comparing quality of life, body image after breast cancer surgery
Daan De Maeseneer
MICHIEL STRIJBOS
Phillip Blondeel
Rudy Van den Broecke
Herman Depypere
Geert Braems
Hannelore Denys
Simon Van Belle
Veronique Cocquyt
C3
Conference
2013
Proctological problems in relation to chemotherapy
Tom Lagaert
BRUNO VANDUYFHUYS
BEATRIJS STRUBBE
INGRID BRUGGEMAN
KOEN GORLEER
Pieter Hindryckx
Daan De Maeseneer
Ine Moors
Stéphanie Laurent
Karen Geboes
et al.
C3
Conference
2013
2010
18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours
Daan De Maeseneer
Bieke Lambert
Veerle Surmont
Karen Geboes
Sylvie Rottey
A1
Journal Article
in
ACTA CLINICA BELGICA
2010
2007
Cell motility and breast cancer metastasis.
Marc Bracke
Daan De Maeseneer
Veerle Van Marck
Lara Derycke
Barbara Vanhoecke
Olivier De Wever
Herman Depypere
Bookchapter
in
Metastasis of Breast Cancer.
2007